• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗真菌治疗与非中性粒细胞减少危重症患者真菌感染预防的关联。

Associations of Antifungal Treatments With Prevention of Fungal Infection in Critically Ill Patients Without Neutropenia.

机构信息

Department of Biopathology and Medical Biotechnologies, Section of Anesthesia Analgesia Intensive Care and Emergency, University of Palermo, Palermo, Italy.

出版信息

JAMA. 2017 Jan 17;317(3):311-312. doi: 10.1001/jama.2016.16535.

DOI:10.1001/jama.2016.16535
PMID:28114533
Abstract

CLINICAL QUESTION

Are antifungal agents associated with lower rates of mortality and invasive fungal infections when administered before definitive diagnosis of an invasive fungal infection in critically ill patients without neutropenia?

BOTTOM LINE

Antifungal treatment administered prior to diagnosis of an invasive fungal infection is not associated with either higher or lower rates of all-cause mortality. Antifungal treatment in this setting is associated with lower rates of invasive fungal infections compared with placebo or no intervention in critically ill patients without neutropenia, but the quality of the evidence is low.

摘要

临床问题

在没有中性粒细胞减少症的危重症患者中,在明确诊断侵袭性真菌感染之前使用抗真菌药物是否与死亡率和侵袭性真菌感染率降低相关?

结论

在侵袭性真菌感染确诊之前使用抗真菌药物与全因死亡率的升高或降低均无关。与安慰剂或不干预相比,在没有中性粒细胞减少症的危重症患者中,该治疗方案与侵袭性真菌感染发生率降低相关,但证据质量较低。

相似文献

1
Associations of Antifungal Treatments With Prevention of Fungal Infection in Critically Ill Patients Without Neutropenia.抗真菌治疗与非中性粒细胞减少危重症患者真菌感染预防的关联。
JAMA. 2017 Jan 17;317(3):311-312. doi: 10.1001/jama.2016.16535.
2
Empiric antifungal therapy in patients with febrile neutropenia.经验性抗真菌治疗发热性中性粒细胞减少症患者。
Pharmacotherapy. 2011 Apr;31(4):369-85. doi: 10.1592/phco.31.4.369.
3
Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trials.用于预防非中性粒细胞减少的重症患者和外科手术患者真菌感染的抗真菌药物:随机临床试验的系统评价和荟萃分析
J Antimicrob Chemother. 2006 Apr;57(4):628-38. doi: 10.1093/jac/dki491. Epub 2006 Feb 3.
4
How to select an antifungal agent in critically ill patients.如何在危重症患者中选择抗真菌药物。
J Crit Care. 2013 Oct;28(5):717-27. doi: 10.1016/j.jcrc.2013.04.006.
5
EPICO 3.0. Empirical antifungal therapy in critically-ill hematology patients.EPICO 3.0。危重症血液病患者的经验性抗真菌治疗。
Rev Iberoam Micol. 2016 Oct-Dec;33(4):206-215. doi: 10.1016/j.riam.2016.06.002. Epub 2016 Oct 15.
6
[Invasive fungal infection in critically ill patient: role of micafungin].
Rev Esp Quimioter. 2012 Mar;25(1):4-9.
7
[Antifungal treatment options in the critically ill patient].[危重症患者的抗真菌治疗选择]
Rev Iberoam Micol. 2012 Apr-Jun;29(2):108-13. doi: 10.1016/j.riam.2012.03.009.
8
Epidemiology, diagnosis and treatment of fungal respiratory infections in the critically ill patient.危重症患者真菌性呼吸道感染的流行病学、诊断与治疗
Rev Esp Quimioter. 2013 Jun;26(2):173-88.
9
Wait and see or rush and switch? New questions for the management of patients with febrile neutropenia receiving antifungal prophylaxis.等待观察还是匆忙换药?发热性中性粒细胞减少症患者接受抗真菌预防治疗管理的新问题。
Mycoses. 2011 Jan;54 Suppl 1:1-6. doi: 10.1111/j.1439-0507.2010.01978.x.
10
Invasive fungal infections in the ICU.重症监护病房中的侵袭性真菌感染。
J Intensive Care Med. 2010 Mar-Apr;25(2):78-92. doi: 10.1177/0885066609355262. Epub 2009 Dec 1.

引用本文的文献

1
Impact of early empirical antifungal therapy on prognosis of sepsis patients with positive yeast culture: A retrospective study from the MIMIC-IV database.早期经验性抗真菌治疗对酵母培养阳性脓毒症患者预后的影响:一项来自MIMIC-IV数据库的回顾性研究
Front Microbiol. 2022 Nov 17;13:1047889. doi: 10.3389/fmicb.2022.1047889. eCollection 2022.
2
Intensive Care Antifungal Stewardship Programme Based on T2Candida PCR and Mannan Antigen: A Prospective Study.基于T2念珠菌聚合酶链反应和甘露聚糖抗原的重症监护抗真菌管理计划:一项前瞻性研究
J Fungi (Basel). 2021 Dec 6;7(12):1044. doi: 10.3390/jof7121044.
3
Tetrahedral DNA nanostructure improves transport efficiency and anti-fungal effect of histatin 5 against Candida albicans.
四面体 DNA 纳米结构提高了组蛋白 5 对白色念珠菌的转运效率和抗真菌作用。
Cell Prolif. 2021 May;54(5):e13020. doi: 10.1111/cpr.13020. Epub 2021 Mar 11.
4
Implications of the presence of yeasts in tracheobronchial secretions of critically ill intubated patients.重症插管患者气管支气管分泌物中酵母菌存在的影响
EXCLI J. 2019 Sep 9;18:801-811. doi: 10.17179/excli2019-1631. eCollection 2019.
5
Choosing the Right Antifungal Agent in ICU Patients.在 ICU 患者中选择合适的抗真菌药物。
Adv Ther. 2019 Dec;36(12):3308-3320. doi: 10.1007/s12325-019-01115-0. Epub 2019 Oct 15.
6
Procalcitonin levels in candidemia versus bacteremia: a systematic review.降钙素原水平在念珠菌血症与菌血症中的比较:一项系统综述。
Crit Care. 2019 May 28;23(1):190. doi: 10.1186/s13054-019-2481-y.
7
Epidemiology, clinical characteristics, resistance, and treatment of infections by .……感染的流行病学、临床特征、耐药性及治疗情况
J Intensive Care. 2018 Oct 29;6:69. doi: 10.1186/s40560-018-0342-4. eCollection 2018.
8
Untargeted Antifungal Treatment in Nonneutropenic Critically Ill Patients: Should Further Studies Be Performed Based on Trial Sequential Analysis Results?非中性粒细胞减少的重症患者的非靶向抗真菌治疗:是否应根据序贯试验分析结果开展进一步研究?
Antimicrob Agents Chemother. 2018 Jun 26;62(7). doi: 10.1128/AAC.00810-18. Print 2018 Jul.
9
Procalcitonin for the diagnosis of invasive candidiasis: what is the evidence?降钙素原用于侵袭性念珠菌病的诊断:证据有哪些?
J Intensive Care. 2017 Sep 25;5:58. doi: 10.1186/s40560-017-0252-x. eCollection 2017.
10
Lessons from uncertainty on antifungal treatment in ICU.重症监护病房抗真菌治疗不确定性的经验教训。
J Thorac Dis. 2017 Apr;9(4):E390-E391. doi: 10.21037/jtd.2017.03.65.